How Much Does Wegovy Cost in 2026? Pricing and Coverage

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Wegovy pricing generates so many searches because the gap between the headline number and the amount people actually pay can be enormous, and that gap is entirely explained by coverage rules rather than by the medication. Before you compare quotes, anchor the pathway-level basics at the PlexusDx Education Hub, then walk through what genuinely determines a Wegovy bill as of April 2026.

The headline number and what it hides

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). That figure is the highest number in the conversation and the one almost nobody with coverage pays. List price is the pre-adjustment sticker that sits ahead of insurance, rebates, manufacturer savings cards, and pharmacy negotiation. Treat it as the ceiling, not the expectation. The useful work is figuring out which discounts and coverage rules pull your specific number down from that ceiling.

How your plan decides what Wegovy costs

Commercial coverage of Wegovy turns on the FDA-approved indication written on the prescription and on your plan's formulary and prior authorization criteria. Plans commonly cover GLP-1 receptor agonists for type 2 diabetes, but Wegovy's chronic weight management indication is treated less predictably: expect BMI-based prior authorization on many plans, step-therapy requirements on others, and outright exclusions on some. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. A direct call to your plan asking about formulary status, indication coverage, and prior authorization is the fastest way to replace guesswork with a real number.

Manufacturer savings and third-party coupons

Novo Nordisk publishes a manufacturer savings card program that can substantially lower monthly out-of-pocket cost for eligible commercially-insured patients. As with other GLP-1 cards, eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps that are revised periodically. Confirm the live terms on the manufacturer website when you fill. Independent platforms such as GoodRx and SingleCare publish separate coupon prices that shift by pharmacy, so the counter price for the identical prescription can differ across two pharmacies on the same street.

What the 2024-2025 compounding changes mean

When the FDA listed semaglutide and tirzepatide as being in shortage, 503A compounding pharmacies were legally allowed to produce compounded formulations of those molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without eliminating every legitimate compounding pathway. Compounded semaglutide and tirzepatide remain available through licensed pharmacies where clinically justified. Keep two facts straight: compounded products are not identical to FDA-approved brand products, and they are priced separately rather than sold as discounted versions of the brand.

Mapping your realistic out-of-pocket cost

Most people land in one of three situations. With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. With commercial insurance that does not cover the indication, cash cost sits closer to list price minus whatever coupon applies. Without insurance, cash cost approaches list. Set against those, the compounded route through the PlexusDx Weight Management Protocols follows its own published pricing on each product page, which is why comparing your covered price, your cash price, and the compounded price together is the honest way to answer "how do I get Wegovy cheaper."

The variable coverage cannot tell you: your genes

Even the best price only answers half the question. How your body engages the GLP-1 pathway you are paying for is the other half, and it is written partly in your genetics. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, and MC4R that shape appetite regulation, satiety, and baseline energy-balance biology. This is trait and pathway education, not prediction: the test does not predict response to Wegovy or any specific medication and is not pharmacogenomic. Bringing that upstream context to your provider makes the money you spend a more informed decision.

Frequently Asked Questions

How much does Wegovy cost per month?

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026 based on Novo Nordisk published pricing. Insurance coverage, manufacturer savings cards, and pharmacy pricing can substantially change the counter price, so verify the current figure with your pharmacy before you fill.

Why is my Wegovy price different from a friend's?

Because coverage is individual. Your plan's formulary, the FDA indication on your prescription, prior authorization outcome, and savings-card eligibility all differ from someone else's. Two people can be quoted very different numbers for the same drug purely because their plans and indications are not the same.

Are there lower-cost alternatives to Wegovy?

Licensed 503A compounding pharmacies produce compounded semaglutide and tirzepatide at separate price points from the FDA-approved brand. These are legally and factually distinct products, not generics. The PlexusDx Weight Management Protocols publish per-protocol pricing on each product page so you can compare pathways directly.

Does a genetic test predict whether Wegovy will work?

No. The Precision Peptide Genetic Test does not predict response to Wegovy or any medication and is not a pharmacogenomic tool. It maps pathway-level variants such as FTO, and MC4R that influence appetite and energy-balance biology, giving you upstream context for a provider conversation.

Add biology to the budget: return to the PlexusDx Education Hub or take the Precision Peptide Genetic Test.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.